[HTML][HTML] Purinergic signalling: therapeutic developments

G Burnstock - Frontiers in pharmacology, 2017 - frontiersin.org
Purinergic signalling, ie, the role of nucleotides as extracellular signalling molecules, was
proposed in 1972. However, this concept was not well accepted until the early 1990's when …

[HTML][HTML] Purinergic signalling in the urinary tract in health and disease

G Burnstock - Purinergic signalling, 2014 - Springer
Purinergic signalling is involved in a number of physiological and pathophysiological
activities in the lower urinary tract. In the bladder of laboratory animals there is …

[HTML][HTML] Molecular mechanisms of neurogenic lower urinary tract dysfunction after spinal cord injury

N Shimizu, T Saito, N Wada, M Hashimoto… - International journal of …, 2023 - mdpi.com
This article provides a synopsis of current progress made in fundamental studies of lower
urinary tract dysfunction (LUTD) after spinal cord injury (SCI) above the sacral level. Animal …

[HTML][HTML] Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: role of adenosine triphosphate

SJ Bonvini, MA Birrell, MS Grace, SA Maher… - Journal of Allergy and …, 2016 - Elsevier
Background Sensory nerves innervating the airways play an important role in regulating
various cardiopulmonary functions, maintaining homeostasis under healthy conditions and …

The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity

MJ Drake, A Kanai, DA Bijos, Y Ikeda… - BJU …, 2017 - Wiley Online Library
The isolated bladder shows autonomous micromotions, which increase with bladder
distension, generate sensory nerve activity, and are altered in models of urinary dysfunction …

Potential future pharmacological treatment of bladder dysfunction

KE Andersson - Basic & clinical pharmacology & toxicology, 2016 - Wiley Online Library
In the last decades, a number of new antimuscarinic drugs have been introduced for
treatment of the overactive bladder (OAB), defined symptomatically (OAB syndrome) or …

[HTML][HTML] Nociceptive transmission and modulation via P2X receptors in central pain syndrome

YH Kuan, BC Shyu - Molecular brain, 2016 - Springer
Painful sensations are some of the most frequent complaints of patients who are admitted to
local medical clinics. Persistent pain varies according to its causes, often resulting from local …

Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms

R Soler, KE Andersson, MB Chancellor, CR Chapple… - European urology, 2013 - Elsevier
Background The pathophysiology of male lower urinary tract symptoms (LUTS) is highly
complex and multifactorial. The shift in perception that LUTS are not sex or organ specific …

Efficacy and safety of eliapixant in overactive bladder: the 12-week, randomised, placebo-controlled phase 2a OVADER study

F Ewerton, F Cruz, M Kapp, S Klein, P Roehm… - European Urology …, 2024 - Elsevier
Background Effective, well-tolerated novel treatments for overactive bladder (OAB) are
lacking. The P2X3 receptor antagonist eliapixant demonstrated potential to reduce OAB …

Purinergic signalling in the urinary bladder

KE Andersson - Autonomic Neuroscience, 2015 - Elsevier
It is well established that in most species, exocytotic vesicular release of ATP from
parasympathetic neurons contributes to contraction of the bladder. However, ATP is …